Summit Therapeutics (SMMT) Earnings Date, Estimates & Call Transcripts $23.70 -0.72 (-2.95%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$23.81 +0.11 (+0.46%) As of 08/29/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Summit Therapeutics Earnings Summary Summit Therapeutics released Q2 2025 earnings on August 11, 2025, reporting an EPS of -$0.76, which missed the consensus estimate of -$0.10 by $0.66. With a trailing EPS of -$1.01, Summit Therapeutics' earnings are expected to decrease next year, from ($0.30) to ($0.36) per share. Upcoming Q3 Earnings DateOct. 29Before Market OpensEstimatedConsensus EPS (Aug. 11) -$0.10 Actual EPS (Aug. 11) -$0.76 Missed By -$0.66 Q2 2025 Earnings ResourcesQ2 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)SEC FilingSMMT Upcoming EarningsSummit Therapeutics' next earnings date is estimated for Wednesday, October 29, 2025, based on past reporting schedules. Powered by Get Summit Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Summit Therapeutics and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataSMMT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SMMT Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Summit Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.09-$0.09-$0.09Q2 20252-$0.10-$0.09-$0.10Q3 20252-$0.10-$0.10-$0.10Q4 20252-$0.11-$0.10-$0.11 FY 2025 7 -$0.40 -$0.38 -$0.39 Q1 20261-$0.09-$0.09-$0.09Q2 20261-$0.09-$0.09-$0.09Q3 20261-$0.09-$0.09-$0.09Q4 20261-$0.09-$0.09-$0.09 Summit Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 10/29/2025(Estimated)--------8/11/2025Q2 2025-$0.10-$0.76 -$0.66-$0.76--5/1/2025Q1 2025-$0.10-$0.09+$0.01-$0.09--2/24/2025Q4 2024-$0.08-$0.08--$0.08-$0.20M10/30/2024Q3 2024-$0.06-$0.08 -$0.02-$0.08--8/6/2024Q2 2024-$0.06-$0.05+$0.01-$0.01--5/1/2024Q1 2024-$0.06-$0.05+$0.01-$0.04--2/20/2024Q4 2023--$0.05--$0.05-$0.20M11/7/2023Q3 2023--$0.03--$0.03-$0.27M Summit Therapeutics Earnings - Frequently Asked Questions When is Summit Therapeutics' earnings date? Summit Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 29th, 2025 based off last year's report dates. Learn more on SMMT's earnings history. Did Summit Therapeutics beat their earnings estimates last quarter? In the previous quarter, Summit Therapeutics (NASDAQ:SMMT) missed the analysts' consensus estimate of ($0.10) by $0.66 with a reported earnings per share (EPS) of ($0.76). Learn more on analysts' earnings estimate vs. SMMT's actual earnings. How can I view Summit Therapeutics' earnings report? Summit Therapeutics' earnings report can be found in their filing with the SEC. View SEC filing How much profit does Summit Therapeutics generate each year? Summit Therapeutics (NASDAQ:SMMT) has a recorded net income of -$221.32 million. SMMT has generated -$1.01 earnings per share over the last four quarters. What is Summit Therapeutics' EPS forecast for next year? Summit Therapeutics' earnings are expected to decrease from ($0.30) per share to ($0.36) per share in the next year. More Earnings Resources from MarketBeat Related Companies Merck & Co., Inc. Earnings Results Takeda Pharmaceutical Earnings Results argenex Earnings Results BeOne Medicines Earnings Results Insmed Earnings Results BioNTech Earnings Results Teva Pharmaceutical Industries Earnings Results Genmab A/S Earnings Results Viatris Earnings Results Dr. Reddy's Laboratories Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy?NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B Contract This page (NASDAQ:SMMT) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredMy NEXT $1 Trillion PredictionJames Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Summit Therapeutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Summit Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SMMT Stock Alerts